Innovative Medical Management Co Ltd (002173) - Net Assets
Based on the latest financial reports, Innovative Medical Management Co Ltd (002173) has net assets worth CN¥1.79 Billion CNY (≈ $261.87 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥2.18 Billion ≈ $318.75 Million USD) and total liabilities (CN¥388.70 Million ≈ $56.88 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Innovative Medical Management Co Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥1.79 Billion |
| % of Total Assets | 82.16% |
| Annual Growth Rate | 16.62% |
| 5-Year Change | -17.13% |
| 10-Year Change | 329.9% |
| Growth Volatility | 166.62 |
Innovative Medical Management Co Ltd - Net Assets Trend (2004–2024)
This chart illustrates how Innovative Medical Management Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Innovative Medical Management Co Ltd (002173) total assets for the complete picture of this company's asset base.
Annual Net Assets for Innovative Medical Management Co Ltd (2004–2024)
The table below shows the annual net assets of Innovative Medical Management Co Ltd from 2004 to 2024. For live valuation and market cap data, see 002173 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.78 Billion ≈ $260.05 Million |
-5.02% |
| 2023-12-31 | CN¥1.87 Billion ≈ $273.80 Million |
-1.79% |
| 2022-12-31 | CN¥1.91 Billion ≈ $278.80 Million |
-4.30% |
| 2021-12-31 | CN¥1.99 Billion ≈ $291.33 Million |
-7.16% |
| 2020-12-31 | CN¥2.14 Billion ≈ $313.80 Million |
-13.18% |
| 2019-12-31 | CN¥2.47 Billion ≈ $361.43 Million |
-31.70% |
| 2018-12-31 | CN¥3.62 Billion ≈ $529.21 Million |
-1.08% |
| 2017-12-31 | CN¥3.66 Billion ≈ $534.98 Million |
+3.51% |
| 2016-12-31 | CN¥3.53 Billion ≈ $516.83 Million |
+754.42% |
| 2015-12-31 | CN¥413.37 Million ≈ $60.49 Million |
-13.63% |
| 2014-12-31 | CN¥478.62 Million ≈ $70.04 Million |
-4.57% |
| 2013-12-31 | CN¥501.53 Million ≈ $73.39 Million |
-3.59% |
| 2012-12-31 | CN¥520.22 Million ≈ $76.12 Million |
+11.63% |
| 2011-12-31 | CN¥466.02 Million ≈ $68.19 Million |
+7.29% |
| 2010-12-31 | CN¥434.36 Million ≈ $63.56 Million |
+7.54% |
| 2009-12-31 | CN¥403.89 Million ≈ $59.10 Million |
+3.14% |
| 2008-12-31 | CN¥391.58 Million ≈ $57.30 Million |
+11.92% |
| 2007-12-31 | CN¥349.87 Million ≈ $51.20 Million |
+160.76% |
| 2006-12-31 | CN¥134.18 Million ≈ $19.63 Million |
+31.11% |
| 2005-12-31 | CN¥102.34 Million ≈ $14.98 Million |
+24.65% |
| 2004-12-31 | CN¥82.10 Million ≈ $12.01 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Innovative Medical Management Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11064.3% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥441.28 Million | 24.84% |
| Other Comprehensive Income | CN¥43.83 Million | 2.47% |
| Other Components | CN¥2.69 Billion | 151.41% |
| Total Equity | CN¥1.78 Billion | 100.00% |
Innovative Medical Management Co Ltd Competitors by Market Cap
The table below lists competitors of Innovative Medical Management Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ruentex Industries Ltd
TW:2915
|
$1.50 Billion |
|
Greatech Technology Bhd
KLSE:0208
|
$1.50 Billion |
|
SoftwareONE Holding AG
SW:SWON
|
$1.50 Billion |
|
Harbin Electric Coporation Jiamusi Electric Machine Co Ltd
SHE:000922
|
$1.50 Billion |
|
Zhejiang Hisoar Pharmaceutical Co Ltd
SHE:002099
|
$1.50 Billion |
|
Zhejiang Shaoxing RuiFeng Rural Commercial Bank Co Ltd
SHG:601528
|
$1.50 Billion |
|
Dalian Zeus Entertainment
SHE:002354
|
$1.50 Billion |
|
China Yuchai International Limited
NYSE:CYD
|
$1.50 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Innovative Medical Management Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,870,152,115 to 1,776,198,085, a change of -93,954,030 (-5.0%).
- Net loss of 93,954,025 reduced equity.
- Dividend payments of 2,591,332 reduced retained earnings.
- Other comprehensive income increased equity by 43,827,802.
- Other factors decreased equity by 41,236,475.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-93.95 Million | -5.29% |
| Dividends Paid | CN¥2.59 Million | -0.15% |
| Other Comprehensive Income | CN¥43.83 Million | +2.47% |
| Other Changes | CN¥-41.24 Million | -2.32% |
| Total Change | CN¥- | -5.02% |
Book Value vs Market Value Analysis
This analysis compares Innovative Medical Management Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.78x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 50.07x to 5.78x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2004-12-31 | CN¥0.46 | CN¥23.26 | x |
| 2005-12-31 | CN¥0.57 | CN¥23.26 | x |
| 2006-12-31 | CN¥0.73 | CN¥23.26 | x |
| 2007-12-31 | CN¥1.95 | CN¥23.26 | x |
| 2008-12-31 | CN¥1.76 | CN¥23.26 | x |
| 2009-12-31 | CN¥1.87 | CN¥23.26 | x |
| 2010-12-31 | CN¥1.92 | CN¥23.26 | x |
| 2011-12-31 | CN¥2.12 | CN¥23.26 | x |
| 2012-12-31 | CN¥2.38 | CN¥23.26 | x |
| 2013-12-31 | CN¥2.54 | CN¥23.26 | x |
| 2014-12-31 | CN¥2.21 | CN¥23.26 | x |
| 2015-12-31 | CN¥2.02 | CN¥23.26 | x |
| 2016-12-31 | CN¥8.00 | CN¥23.26 | x |
| 2017-12-31 | CN¥8.05 | CN¥23.26 | x |
| 2018-12-31 | CN¥8.53 | CN¥23.26 | x |
| 2019-12-31 | CN¥5.43 | CN¥23.26 | x |
| 2020-12-31 | CN¥4.71 | CN¥23.26 | x |
| 2021-12-31 | CN¥4.44 | CN¥23.26 | x |
| 2022-12-31 | CN¥4.28 | CN¥23.26 | x |
| 2023-12-31 | CN¥4.21 | CN¥23.26 | x |
| 2024-12-31 | CN¥4.03 | CN¥23.26 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Innovative Medical Management Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -5.29%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -11.51%
- • Asset Turnover: 0.37x
- • Equity Multiplier: 1.24x
- Recent ROE (-5.29%) is below the historical average (1.45%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2004 | 24.40% | 11.35% | 1.05x | 2.05x | CN¥10.14 Million |
| 2005 | 18.09% | 8.02% | 0.76x | 2.97x | CN¥6.90 Million |
| 2006 | 23.73% | 10.99% | 0.64x | 3.40x | CN¥15.17 Million |
| 2007 | 11.10% | 12.13% | 0.49x | 1.88x | CN¥3.51 Million |
| 2008 | 10.51% | 10.86% | 0.52x | 1.85x | CN¥1.83 Million |
| 2009 | 3.21% | 4.15% | 0.37x | 2.11x | CN¥-24.89 Million |
| 2010 | 7.28% | 9.94% | 0.35x | 2.10x | CN¥-10.73 Million |
| 2011 | 7.08% | 9.09% | 0.37x | 2.13x | CN¥-12.41 Million |
| 2012 | 7.98% | 10.34% | 0.36x | 2.12x | CN¥-9.64 Million |
| 2013 | 4.73% | 7.93% | 0.28x | 2.10x | CN¥-26.44 Million |
| 2014 | -2.27% | -5.91% | 0.18x | 2.17x | CN¥-58.70 Million |
| 2015 | -15.81% | -47.68% | 0.13x | 2.60x | CN¥-106.67 Million |
| 2016 | 3.25% | 15.04% | 0.17x | 1.29x | CN¥-238.44 Million |
| 2017 | 3.85% | 16.74% | 0.18x | 1.27x | CN¥-224.81 Million |
| 2018 | 0.82% | 2.95% | 0.24x | 1.18x | CN¥-331.91 Million |
| 2019 | -46.58% | -131.85% | 0.29x | 1.20x | CN¥-1.40 Billion |
| 2020 | -14.67% | -43.42% | 0.27x | 1.25x | CN¥-528.85 Million |
| 2021 | -5.20% | -14.54% | 0.28x | 1.28x | CN¥-302.45 Million |
| 2022 | -3.86% | -10.35% | 0.30x | 1.23x | CN¥-263.86 Million |
| 2023 | -1.83% | -4.26% | 0.35x | 1.22x | CN¥-221.30 Million |
| 2024 | -5.29% | -11.51% | 0.37x | 1.24x | CN¥-271.57 Million |
Industry Comparison
This section compares Innovative Medical Management Co Ltd's net assets metrics with peer companies in the Luxury Goods industry.
Industry Context
- Industry: Luxury Goods
- Average net assets among peers: $2,212,685,175
- Average return on equity (ROE) among peers: 6.64%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Innovative Medical Management Co Ltd (002173) | CN¥1.79 Billion | 24.40% | 0.22x | $1.50 Billion |
| Shenzhen Tellus Holding Co Ltd (000025) | $908.54 Million | 2.99% | 0.31x | $954.10 Million |
| Fiyta Holdings Ltd (000026) | $540.87 Million | 2.96% | 0.15x | $968.83 Million |
| Guangdong CHJ Industry Co Ltd (002345) | $3.59 Billion | 5.54% | 0.55x | $1.37 Billion |
| Zhejiang Ming Jewelry Co Ltd (002574) | $2.87 Billion | 2.91% | 0.70x | $441.17 Million |
| Beijing Kingee Culture Development Co Ltd (002721) | $2.99 Billion | 5.83% | 2.62x | $1.19 Billion |
| Shenyang Cuihua Gold and Silver Jewelry Co Ltd (002731) | $1.78 Billion | 12.15% | 2.27x | $163.05 Million |
| Chow Tai Seng Jewellery Co Ltd (002867) | $3.38 Billion | 17.51% | 0.30x | $2.11 Billion |
| Shenzhen Tellus Holding Co Ltd (200025) | $1.38 Billion | 4.16% | 0.23x | $21.50 Million |
| Fiyta Holdings Ltd (200026) | $2.47 Billion | 5.68% | 0.45x | $36.57 Million |
About Innovative Medical Management Co Ltd
Innovative Medical Management Co.,Ltd. engages in the medical services business in China. The company owns and operates Jianhua Hospital, Kanghua Hospital, Futian Hospital, and Mingzhu Hospital. It also offers outpatient, inpatient, and physical examination services. The company was formerly known as Qianzu Pearl Group Co., Ltd. and changed its name to Innovative Medical Management Co.,Ltd. in Ju… Read more